Gallbladder problems, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), have been reported with GLP-1 receptor agonists, likely related to rapid weight loss
11%, p = 0.03) at baseline
Sleep disturbances, including insomnia or vivid dreams, have been reported by a small percentage of patients
Both have undergone rigorous Phase 2 and Phase 3 testing, producing substantial datasets that reveal their weight loss potential
Prevention and Management : To prevent dizziness, sit or lie down immediately after receiving injections
Success Stories at our West Nashville Center Frequently Asked Questions About BPC-157 The primary goal of BPC-157 is to accelerate your bodys natural repair of muscles, tendons, ligaments, and the gut lining